» Articles » PMID: 39094564

Sestrin2 Drives ER-phagy in Response to Protein Misfolding

Abstract

Protein biogenesis within the endoplasmic reticulum (ER) is crucial for organismal function. Errors during protein folding necessitate the removal of faulty products. ER-associated protein degradation and ER-phagy target misfolded proteins for proteasomal and lysosomal degradation. The mechanisms initiating ER-phagy in response to ER proteostasis defects are not well understood. By studying mouse primary cells and patient samples as a model of ER storage disorders (ERSDs), we show that accumulation of faulty products within the ER triggers a response involving SESTRIN2, a nutrient sensor controlling mTORC1 signaling. SESTRIN2 induction by XBP1 inhibits mTORC1's phosphorylation of TFEB/TFE3, allowing these transcription factors to enter the nucleus and upregulate the ER-phagy receptor FAM134B along with lysosomal genes. This response promotes ER-phagy of misfolded proteins via FAM134B-Calnexin complex. Pharmacological induction of FAM134B improves clearance of misfolded proteins in ERSDs. Our study identifies the interplay between nutrient signaling and ER quality control, suggesting therapeutic strategies for ERSDs.

Citing Articles

Integrative Multi-Omics Approach in Vascular Ehlers-Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts.

Chiarelli N, Cinquina V, Zoppi N, Bertini V, Maddaluno M, De Leonibus C Biomedicines. 2025; 12(12.

PMID: 39767655 PMC: 11727028. DOI: 10.3390/biomedicines12122749.


Non-genetic diagnostic investigations in monogenic Ehlers-Danlos syndromes.

van Dijk F, Angwin C, Ghali N, Zschocke J, Wagner B Med Genet. 2024; 36(4):247-254.

PMID: 39629472 PMC: 11610441. DOI: 10.1515/medgen-2024-2062.


Signaling Regulation of FAM134-Dependent ER-Phagy in Cells.

Palma A, Reggio A J Cell Physiol. 2024; 240(1):e31492.

PMID: 39584582 PMC: 11747952. DOI: 10.1002/jcp.31492.


Homeostasis control in health and disease by the unfolded protein response.

Acosta-Alvear D, Harnoss J, Walter P, Ashkenazi A Nat Rev Mol Cell Biol. 2024; 26(3):193-212.

PMID: 39501044 DOI: 10.1038/s41580-024-00794-0.

References
1.
Cross B, Bond P, Sadowski P, Jha B, Zak J, Goodman J . The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A. 2012; 109(15):E869-78. PMC: 3326519. DOI: 10.1073/pnas.1115623109. View

2.
Cinque L, De Leonibus C, Iavazzo M, Krahmer N, Intartaglia D, Salierno F . MiT/TFE factors control ER-phagy via transcriptional regulation of FAM134B. EMBO J. 2020; 39(17):e105696. PMC: 7459426. DOI: 10.15252/embj.2020105696. View

3.
Cunningham C, Williams J, Knupp J, Arunagiri A, Arvan P, Tsai B . Cells Deploy a Two-Pronged Strategy to Rectify Misfolded Proinsulin Aggregates. Mol Cell. 2019; 75(3):442-456.e4. PMC: 6688957. DOI: 10.1016/j.molcel.2019.05.011. View

4.
Napolitano F, Carrella D, Mandriani B, Pisonero-Vaquero S, Sirci F, Medina D . gene2drug: a computational tool for pathway-based rational drug repositioning. Bioinformatics. 2017; 34(9):1498-1505. DOI: 10.1093/bioinformatics/btx800. View

5.
Iavarone F, Di Lorenzo G, Settembre C . Regulatory events controlling ER-phagy. Curr Opin Cell Biol. 2022; 76:102084. DOI: 10.1016/j.ceb.2022.102084. View